Mycetoma: An Update

Mycetoma is a localized chronic, suppurative, and deforming granulomatous infection seen in tropical and subtropical areas. It is a disorder of subcutaneous tissue, skin and bones, mainly of feet, characterized by a triad of localized swelling, underlying sinus tracts, and production of grains or granules. Etiological classification divides it into eumycetoma caused by fungus, and actinomycetoma caused by bacteria. Since the treatment of these two etiologies is entirely different, a definite diagnosis after histopathological and microbiological examination is mandatory, though difficult. Serological test exists but is not so reliable; however, molecular techniques to identify relevant antigens have shown promise. The disease is notoriously difficult to treat. Eumycetoma may be unresponsive to standard antifungal therapy. Actinomycetoma responds to antibiotic therapy, but prolonged treatment is necessary.This review focuses on the etiopathogenesis, clinical features, laboratory diagnosis, and treatment of mycetoma.

[1]  M. Goodfellow,et al.  Mycetoma: a unique neglected tropical disease. , 2016, The Lancet. Infectious diseases.

[2]  A. Fahal,et al.  Eumycetoma and actinomycetoma – an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  G. S. de Hoog,et al.  Madurella mycetomatis Is Highly Susceptible to Ravuconazole , 2014, PLoS neglected tropical diseases.

[4]  J. Meis,et al.  In Vitro Antifungal Activity of Isavuconazole against Madurella mycetomatis , 2012, Antimicrobial Agents and Chemotherapy.

[5]  A. van Belkum,et al.  Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal Agents , 2010, Antimicrobial Agents and Chemotherapy.

[6]  A. Fahal,et al.  Mycetoma in children in Sudan. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  S. Tolat,et al.  Modified Welsh regimen: a promising therapy for actinomycetoma. , 2008, Journal of drugs in dermatology : JDD.

[8]  A. Bonifaz,et al.  Utility of helical computed tomography to evaluate the invasion of actinomycetoma; a report of 21 cases , 2008, The British journal of dermatology.

[9]  M. Mcginnis,et al.  Subcutaneous Fungal Infections (Chromoblastomycosis, Mycetoma, and Lobomycosis) , 2008 .

[10]  C. Linton,et al.  Molecular identification of pathogenic fungi. , 2008, The Journal of antimicrobial chemotherapy.

[11]  A. Zarei Mahmoudabadi,et al.  Mycetomas in Iran: a review article , 2008, Mycopathologia.

[12]  Vinod K. Sharma,et al.  A modified two-step treatment for actinomycetoma. , 2007, Indian journal of dermatology, venereology and leprology.

[13]  M. Augenbraun,et al.  Mycetoma fungal infection: multiple organisms as colonizers or pathogens? , 2007, Revista da Sociedade Brasileira de Medicina Tropical.

[14]  F. Dromer,et al.  Molecular Identification of Black-Grain Mycetoma Agents , 2006, Journal of Clinical Microbiology.

[15]  P. Massip,et al.  Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[16]  M. Dieng,et al.  Clinical efficacy and safety of oral terbinafine in fungal mycetoma , 2006, International journal of dermatology.

[17]  R. Negroni,et al.  Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. , 2005, Revista do Instituto de Medicina Tropical de Sao Paulo.

[18]  S. Tyring,et al.  Tropical dermatology: fungal tropical diseases. , 2004, Journal of the American Academy of Dermatology.

[19]  R. López-martínez,et al.  Nocardia brasiliensis: in vitro and in vivo growth response to steroid sex hormones , 1995, Mycopathologia.

[20]  M. Salinas-Carmona,et al.  Humoral Immunity through Immunoglobulin M Protects Mice from an Experimental Actinomycetoma Infection by Nocardia brasiliensis , 2004, Infection and Immunity.

[21]  A. van Belkum,et al.  In Vitro Susceptibilities of Madurella mycetomatis to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2H- Tetrazolium Hydroxide (XTT) Assay , 2004, Antimicrobial Agents and Chemotherapy.

[22]  A. Fahal Mycetoma: a thorn in the flesh. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  U. Hemal,et al.  Pulse Therapy with Amikacin and Dapsone for the Treatment of Actinomycotic Foot: A Case Report , 2003, The Journal of dermatology.

[24]  I. Sarris,et al.  MRI of mycetoma of the foot: two cases demonstrating the dot-in-circle sign , 2003, Skeletal Radiology.

[25]  M-T Dieng,et al.  [Mycetoma: 130 cases]. , 2003, Annales de dermatologie et de venereologie.

[26]  J. Graybill,et al.  Subcutaneous mycoses. , 2003, Infectious disease clinics of North America.

[27]  S. Bandyopadhyay,et al.  Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal , 2002, Tropical medicine & international health : TM & IH.

[28]  M. L. Khatri,et al.  Mycetoma in Yemen: clinicoepidemiologic and histopathologic study , 2002, International journal of dermatology.

[29]  A. Bonifaz,et al.  Perianal actinomycetoma experience of 20 cases , 2002, International journal of dermatology.

[30]  B. Veress,et al.  The immunopathology of actinomycetoma lesions caused by Streptomyces somaliensis. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[31]  D. Haas,et al.  MR and other imaging methods in the investigation of mycetomas. , 2001, Acta radiologica.

[32]  M. Ramam,et al.  A two-step schedule for the treatment of actinomycotic mycetomas. , 2000, Acta dermato-venereologica.

[33]  A. van Belkum,et al.  Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. , 1999, Journal of clinical microbiology.

[34]  A. Chaiprasert,et al.  Deep fungal and higher bacterial skin infections in Thailand: clinical manifestations and treatment regimens , 1999, International journal of dermatology.

[35]  P. Maiti,et al.  Antibiotic sensitivity patterns of actinomycetes isolated from patients of actinomycetoma. , 1997, The Indian journal of medical research.

[36]  M. C. Salinas,et al.  Treatment of eumycetoma and actinomycetoma. , 1995, Current topics in medical mycology.

[37]  A. Fahal,et al.  The host tissue reaction to Madurella mycetomatis: new classification. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[38]  M. Salinas-Carmona,et al.  Enzyme-linked immunosorbent assay for serological diagnosis of Nocardia brasiliensis and clinical correlation with mycetoma infections , 1993, Journal of clinical microbiology.

[39]  P. V. Venugopal,et al.  TREATMENT OF EUMYCETOMA WITH KETOCONAZOLE , 1993, The Australasian journal of dermatology.

[40]  A. Gómez,et al.  AMOXICILLIN AND CLAVULANIC ACID IN THE TREATMENT OF ACTINOMYCETOMA , 1993, International journal of dermatology.

[41]  P. Lavalle,et al.  [Epidemiology of mycetoma in Mexico: study of 2105 cases]. , 1992, Gaceta medica de Mexico.

[42]  O. Welsh,et al.  Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. , 1987, Journal of the American Academy of Dermatology.

[43]  L. M. Alves,et al.  Studies on the pathogenesis of actinomycotic mycetoma in animals injected with fractions isolated from Nocardia brasiliensis. , 1987, British journal of experimental pathology.

[44]  R. Hay,et al.  Leucocyte chemotaxis to mycetoma agents--the effect of the antifungal drugs griseofulvin and ketoconazole. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[45]  E. Mahgoub,et al.  Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[46]  R. Hay,et al.  Mycetoma (madura foot) in the United Kingdom–a survey of forty‐four cases , 1983, Clinical and experimental dermatology.

[47]  R. Rogers,et al.  Diagnosis and treatment of mycetoma. , 1982, Journal of the American Academy of Dermatology.

[48]  H. Gugnani,et al.  Actinomycetoma in Nigeria. , 1981, The Journal of tropical medicine and hygiene.

[49]  S. Subramanian,et al.  MYCETOMA CAUSED BY MADURELLA MYCETOMII IN MADRAS , 1978, The Australasian journal of dermatology.

[50]  E. Mahgoub Medical management of mycetoma. , 1976, Bulletin of the World Health Organization.

[51]  A. E. El Hassan,et al.  Lymph node involvement in mycetoma. , 1972, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[52]  W. O. Green,et al.  MYCETOMA IN THE UNITED STATES; A REVIEW AND REPORT OF SEVEN ADDITIONAL CASES. , 1964, American journal of clinical pathology.

[53]  R. G. Archibald,et al.  A Sudanese Maduromycosis , 1916 .